Inventor · disambiguated record
Davinder Gill
Also filed as: GILL DAVINDER · GILL DAVINDER S · GILL DAVINDER SINGH
24 granted patents·18 pending applications·305 citations·filing 2000–2021
96Inventor score
Files withWYETH LLC9MSD WELLCOME TRUST HILLEMAN LABORATORIES PVT LTD8WYETH CORP5BLOOM LAIRD4MILLENNIUM PHARM INC4
Top patents by PatentIndex Score
42 records- 0197US7501121B2IL-13 binding agentsWYETH CORP·Filed 2005·Granted Mar 10, 2009·112 cites·41 claims
- 0295US8044178B2Anti-5T4 antibodies and uses thereofWYETH LLC·Filed 2007·Granted Oct 25, 2011·41 cites·31 claims
- 0391US8759495B2Anti-5T4 antibodies and uses thereofBOGHAERT ERWIN R·Filed 2011·Granted Jun 24, 2014·22 cites·33 claims
- 0491US7901684B2Antibodies against human IL-22 and uses thereforWYETH LLC·Filed 2007·Granted Mar 8, 2011·14 cites·10 claims
- 0591US7750122B2Anti-TrkB monoclonal antibodies and uses thereofWYETH LLC·Filed 2006·Granted Jul 6, 2010·28 cites·27 claims
- 0688US7101549B2Glycoprotein VI and uses thereofMILLENNIUM PHARM INC·Filed 2004·Granted Sep 5, 2006·16 cites·16 claims
- 0788US6989144B1Glycoprotein VI antibodies and uses thereofMILLENNIUM PHARM INC·Filed 2000·Granted Jan 24, 2006·22 cites·16 claims
- 0887US7597888B2Glycoprotein VI and uses thereofMILLENNIUM PHARM INC·Filed 2006·Granted Oct 6, 2009·8 cites·16 claims
- 0986US9644025B2Immunotherapy regimes dependent on ApoE statusBLACK RONALD·Filed 2008·Granted May 9, 2017·15 cites·27 claims
- 1083US9902771B2Anti-5T4 antibodies and uses thereofWYETH LLC·Filed 2015·Granted Feb 27, 2018·3 cites·20 claims
- 1179US10532093B2Thermostable freeze dried rotavirus vaccine formulation and process to prepare thereofMSD WELLCOME TRUST HILLEMAN LABORATORIES PVT LTD·Filed 2015·Granted Jan 14, 2020·8 cites·27 claims
- 1276US7943342B2Nucleic acids encoding IL-13 binding agentsWYETH LLC·Filed 2009·Granted May 17, 2011·2 cites·58 claims
- 1374US10011662B2Downstream process for purifying polysaccharidesMSD WELLCOME TRUST HILLEMAN LABORATORIES PVT LTD·Filed 2015·Granted Jul 3, 2018·2 cites·7 claims
- 1473US8187603B2Antibodies to human IL-22GILL DAVINDER S·Filed 2009·Granted May 29, 2012·1 cites·24 claims
- 1573US8163884B2Interleukin-21 receptor binding proteinsBLOOM LAIRD·Filed 2009·Granted Apr 24, 2012·2 cites·21 claims
- 1672US8178097B2Methods of treatment utilizing binding proteins of the interleukin-21 receptorBLOOM LAIRD·Filed 2009·Granted May 15, 2012·4 cites·23 claims
- 1771US9272030B2Use of tau to monitor immunotherapyBLACK RONALD·Filed 2011·Granted Mar 1, 2016·1 cites·16 claims
- 1871US8470993B2Nucleic acid encoding antibody to human IL-22GILL DAVINDER S·Filed 2012·Granted Jun 25, 2013·1 cites·19 claims
- 1969US8182817B2Antibodies to human IL-22GILL DAVINDER S·Filed 2010·Granted May 22, 2012·1 cites·20 claims
- 2065US2010173382A1Humanized anti-5t4 antibodies and anti-5t4/calicheamicin conjugatesWYETH CORP·Filed 2009·Application pending·0 cites
- 2164US10105438B2Process of conjugation and novel synthetic oligosaccharide-protein conjugates obtained thereofMSD WELLCOME TRUST HILLEMAN LABORATORIES PVT LTD·Filed 2015·Granted Oct 23, 2018·2 cites·21 claims
- 2264US2010021483A1Humanized anti-5t4 antibodies and anti-5t4/calicheamicin conjugatesWYETH CORP·Filed 2009·Application pending·0 cites
- 2362US2014308302A1Anti-5t4 antibodies and uses thereofWYETH LLC·Filed 2014·Application pending·0 cites
- 2461US2018162937A1Anti-5t4 antibodies and uses thereofWYETH LLC·Filed 2018·Application pending·0 cites
- 2558US12403190B2Coronavirus vaccine and methods of use thereofGILL DAVINDER·Filed 2021·Granted Sep 2, 2025·0 cites·3 claims
- 2658US2009258005A1Therapeutic compositions and methodsTRUBION PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 2755US2006088522A1Humanized anti-5T4 antibodies and anti-5T4/calicheamicin conjugatesWYETH CORP·Filed 2005·Application pending·0 cites
- 2850US2011262435A1Il-13 binding agentsWYETH LLC·Filed 2011·Application pending·0 cites
- 2950US2004001826A1Glycoprotein VI and uses thereofMILLENNIUM PHARM INC·Filed 2001·Application pending·0 cites
- 3049US2009304590A1Therapeutic compositions and methodsWYETH CORP·Filed 2008·Application pending·0 cites
- 3149US2020147198A1Novel Multivalent Polysaccharide-Protein Conjugate Vaccine Composition and Formulation ThereofMSD WELLCOME TRUST HIIIEMAN LABORATORIES PVT LTD·Filed 2018·Application pending·0 cites
- 3247US2012121505A1Therapeutic compositions and methodsGILL DAVINDER SINGH·Filed 2012·Application pending·0 cites
- 3343US2012264919A1Interleukin-21 receptor binding proteinsBLOOM LAIRD·Filed 2012·Application pending·0 cites
- 3442US2020247911A1Purification of Bacterial PolysaccharidesMSD WELLCOME TRUST HILLEMAN LABORATORIES PVT LTD·Filed 2018·Application pending·0 cites
- 3542US2012070379A1Immunotherapy regimes dependent on apoe statusBLACK RONALD·Filed 2011·Application pending·0 cites
- 3641US2011150893A1Anti-trkb monoclonal antibodies and uses thereofWYETH LLC·Filed 2010·Application pending·0 cites
- 3741US2021254113A1Production of Bacterial PolysaccharidesMSD WELLCOME TRUST HILLEMAN LABORATORIEES PVT LTD·Filed 2018·Application pending·0 cites
- 3839US2020353064A1Novel meningococcal vaccine composition and process thereofMSD WELLCOME TRUST HILLEMAN LABORATORIES PVT LTD·Filed 2019·Application pending·0 cites
- 3938US2012276102A1Methods of treatment utiliziing binding proteins of the interleukin-21 receptorBLOOM LAIRD·Filed 2012·Application pending·0 cites
- 4034US10987415B2Process for production of purified recombinant cholera toxin B (rCTB) and formulation thereonMSD WELLCOME TRUST HILLEMAN LABORATORIES PVT LTD·Filed 2016·Granted Apr 27, 2021·0 cites·10 claims
- 4128US10556000B2Thermostable spray dried rotavirus vaccine formulation and process thereofMSD WELLCOME TRUST HILLEMAN LABORATORIES PVT LTD·Filed 2015·Granted Feb 11, 2020·0 cites·16 claims
- 4224US10183962B2Synthetic oligomers of Neisseria meningitis serogroup X and process of preparing themMSD WELLCOME TRUST HILLEMAN LABORATORIES PVT LTD·Filed 2015·Granted Jan 22, 2019·0 cites·19 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →